Cargando…
Multi-PheWAS intersection approach to identify sex differences across comorbidities in 59 140 pediatric patients with autism spectrum disorder
OBJECTIVE: To identify differences related to sex and define autism spectrum disorder (ASD) comorbidities female-enriched through a comprehensive multi-PheWAS intersection approach on big, real-world data. Although sex difference is a consistent and recognized feature of ASD, additional clinical cor...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757290/ https://www.ncbi.nlm.nih.gov/pubmed/34405856 http://dx.doi.org/10.1093/jamia/ocab144 |
_version_ | 1784632650430939136 |
---|---|
author | Gutiérrez-Sacristán, Alba Sáez, Carlos De Niz, Carlos Jalali, Niloofar DeSain, Thomas N Kumar, Ranjay Zachariasse, Joany M Fox, Kathe P Palmer, Nathan Kohane, Isaac Avillach, Paul |
author_facet | Gutiérrez-Sacristán, Alba Sáez, Carlos De Niz, Carlos Jalali, Niloofar DeSain, Thomas N Kumar, Ranjay Zachariasse, Joany M Fox, Kathe P Palmer, Nathan Kohane, Isaac Avillach, Paul |
author_sort | Gutiérrez-Sacristán, Alba |
collection | PubMed |
description | OBJECTIVE: To identify differences related to sex and define autism spectrum disorder (ASD) comorbidities female-enriched through a comprehensive multi-PheWAS intersection approach on big, real-world data. Although sex difference is a consistent and recognized feature of ASD, additional clinical correlates could help to identify potential disease subgroups, based on sex and age. MATERIALS AND METHODS: We performed a systematic comorbidity analysis on 1860 groups of comorbidities exploring all spectrum of known disease, in 59 140 individuals (11 440 females) with ASD from 4 age groups. We explored ASD sex differences in 2 independent real-world datasets, across all potential comorbidities by comparing (1) females with ASD vs males with ASD and (2) females with ASD vs females without ASD. RESULTS: We identified 27 different comorbidities that appeared significantly more frequently in females with ASD. The comorbidities were mostly neurological (eg, epilepsy, odds ratio [OR] > 1.8, 3-18 years of age), congenital (eg, chromosomal anomalies, OR > 2, 3-18 years of age), and mental disorders (eg, intellectual disability, OR > 1.7, 6-18 years of age). Novel comorbidities included endocrine metabolic diseases (eg, failure to thrive, OR = 2.5, ages 0-2), digestive disorders (gastroesophageal reflux disease: OR = 1.7, 6-11 years of age; and constipation: OR > 1.6, 3-11 years of age), and sense organs (strabismus: OR > 1.8, 3-18 years of age). DISCUSSION: A multi-PheWAS intersection approach on real-world data as presented in this study uniquely contributes to the growing body of research regarding sex-based comorbidity analysis in ASD population. CONCLUSIONS: Our findings provide insights into female-enriched ASD comorbidities that are potentially important in diagnosis, as well as the identification of distinct comorbidity patterns influencing anticipatory treatment or referrals. The code is publicly available (https://github.com/hms-dbmi/sexDifferenceInASD). |
format | Online Article Text |
id | pubmed-8757290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-87572902022-01-13 Multi-PheWAS intersection approach to identify sex differences across comorbidities in 59 140 pediatric patients with autism spectrum disorder Gutiérrez-Sacristán, Alba Sáez, Carlos De Niz, Carlos Jalali, Niloofar DeSain, Thomas N Kumar, Ranjay Zachariasse, Joany M Fox, Kathe P Palmer, Nathan Kohane, Isaac Avillach, Paul J Am Med Inform Assoc Research and Applications OBJECTIVE: To identify differences related to sex and define autism spectrum disorder (ASD) comorbidities female-enriched through a comprehensive multi-PheWAS intersection approach on big, real-world data. Although sex difference is a consistent and recognized feature of ASD, additional clinical correlates could help to identify potential disease subgroups, based on sex and age. MATERIALS AND METHODS: We performed a systematic comorbidity analysis on 1860 groups of comorbidities exploring all spectrum of known disease, in 59 140 individuals (11 440 females) with ASD from 4 age groups. We explored ASD sex differences in 2 independent real-world datasets, across all potential comorbidities by comparing (1) females with ASD vs males with ASD and (2) females with ASD vs females without ASD. RESULTS: We identified 27 different comorbidities that appeared significantly more frequently in females with ASD. The comorbidities were mostly neurological (eg, epilepsy, odds ratio [OR] > 1.8, 3-18 years of age), congenital (eg, chromosomal anomalies, OR > 2, 3-18 years of age), and mental disorders (eg, intellectual disability, OR > 1.7, 6-18 years of age). Novel comorbidities included endocrine metabolic diseases (eg, failure to thrive, OR = 2.5, ages 0-2), digestive disorders (gastroesophageal reflux disease: OR = 1.7, 6-11 years of age; and constipation: OR > 1.6, 3-11 years of age), and sense organs (strabismus: OR > 1.8, 3-18 years of age). DISCUSSION: A multi-PheWAS intersection approach on real-world data as presented in this study uniquely contributes to the growing body of research regarding sex-based comorbidity analysis in ASD population. CONCLUSIONS: Our findings provide insights into female-enriched ASD comorbidities that are potentially important in diagnosis, as well as the identification of distinct comorbidity patterns influencing anticipatory treatment or referrals. The code is publicly available (https://github.com/hms-dbmi/sexDifferenceInASD). Oxford University Press 2021-08-18 /pmc/articles/PMC8757290/ /pubmed/34405856 http://dx.doi.org/10.1093/jamia/ocab144 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research and Applications Gutiérrez-Sacristán, Alba Sáez, Carlos De Niz, Carlos Jalali, Niloofar DeSain, Thomas N Kumar, Ranjay Zachariasse, Joany M Fox, Kathe P Palmer, Nathan Kohane, Isaac Avillach, Paul Multi-PheWAS intersection approach to identify sex differences across comorbidities in 59 140 pediatric patients with autism spectrum disorder |
title | Multi-PheWAS intersection approach to identify sex differences across comorbidities in 59 140 pediatric patients with autism spectrum disorder |
title_full | Multi-PheWAS intersection approach to identify sex differences across comorbidities in 59 140 pediatric patients with autism spectrum disorder |
title_fullStr | Multi-PheWAS intersection approach to identify sex differences across comorbidities in 59 140 pediatric patients with autism spectrum disorder |
title_full_unstemmed | Multi-PheWAS intersection approach to identify sex differences across comorbidities in 59 140 pediatric patients with autism spectrum disorder |
title_short | Multi-PheWAS intersection approach to identify sex differences across comorbidities in 59 140 pediatric patients with autism spectrum disorder |
title_sort | multi-phewas intersection approach to identify sex differences across comorbidities in 59 140 pediatric patients with autism spectrum disorder |
topic | Research and Applications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757290/ https://www.ncbi.nlm.nih.gov/pubmed/34405856 http://dx.doi.org/10.1093/jamia/ocab144 |
work_keys_str_mv | AT gutierrezsacristanalba multiphewasintersectionapproachtoidentifysexdifferencesacrosscomorbiditiesin59140pediatricpatientswithautismspectrumdisorder AT saezcarlos multiphewasintersectionapproachtoidentifysexdifferencesacrosscomorbiditiesin59140pediatricpatientswithautismspectrumdisorder AT denizcarlos multiphewasintersectionapproachtoidentifysexdifferencesacrosscomorbiditiesin59140pediatricpatientswithautismspectrumdisorder AT jalaliniloofar multiphewasintersectionapproachtoidentifysexdifferencesacrosscomorbiditiesin59140pediatricpatientswithautismspectrumdisorder AT desainthomasn multiphewasintersectionapproachtoidentifysexdifferencesacrosscomorbiditiesin59140pediatricpatientswithautismspectrumdisorder AT kumarranjay multiphewasintersectionapproachtoidentifysexdifferencesacrosscomorbiditiesin59140pediatricpatientswithautismspectrumdisorder AT zachariassejoanym multiphewasintersectionapproachtoidentifysexdifferencesacrosscomorbiditiesin59140pediatricpatientswithautismspectrumdisorder AT foxkathep multiphewasintersectionapproachtoidentifysexdifferencesacrosscomorbiditiesin59140pediatricpatientswithautismspectrumdisorder AT palmernathan multiphewasintersectionapproachtoidentifysexdifferencesacrosscomorbiditiesin59140pediatricpatientswithautismspectrumdisorder AT kohaneisaac multiphewasintersectionapproachtoidentifysexdifferencesacrosscomorbiditiesin59140pediatricpatientswithautismspectrumdisorder AT avillachpaul multiphewasintersectionapproachtoidentifysexdifferencesacrosscomorbiditiesin59140pediatricpatientswithautismspectrumdisorder |